—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Bausch + Lomb Corp (BLCO) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for BLCO, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sector × region Health care in US: −2.1% week · −2.2% month · +3.3% quarter · +16.4% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
How it trades on rate days beta 0.55 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How BLCO has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.55 — tends to move with bonds for every 1% move in TLT (20+ year Treasuries), Bausch + Lomb Corp moved 0.55% on average · correlation 0.18 · higher than 57% of US names
  • Beta, last 3 months 0.54 about the same as over the year
  • On the 10 worst bond days −0.71% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −1.47% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Instruments & Supplies · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against BLCO on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Bausch + Lomb Corp

BLCO in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Bausch + Lomb operates as an eye health company, selling across three segments: Vision Care, Pharmaceuticals and Surgical. Vision Care covers contact lenses, lens-care products, vitamins and over-the-counter eye drops. Pharmaceuticals covers treatments for glaucoma, inflammation, dry eye and retinal disease. Surgical covers cataract, corneal, vitreous and retinal devices, including intraocular lenses and phacoemulsification equipment. It sells through direct sales forces and distributors, is headquartered in Vaughan, Canada, and operates as a subsidiary of Bausch Health Companies.
Where it sits in the stack
Bausch + Lomb holds no seat in Rubin, our AI build-out index; it sits in our broader universe under healthcare, in the medical instruments and supplies sector.
Who it is priced against
No peer group is set for this name in our coverage; the comparison the market draws is with Alcon, another eye-care company spanning vision care, pharmaceuticals and surgical devices.
Why Closelooknet tracks it
Bausch + Lomb holds no seat in Rubin or our other indices, and it carries no Closelooknet score; coverage here rests on price and chart structure alone.
What the diary watches
Whether the segment mix shifts, as the diary watches whether Surgical grows relative to Vision Care and Pharmaceuticals, and whether the recent chart pullback continues or steadies.

Bausch + Lomb Corp (BLCO) trades on US exchanges, classified under Healthcare.

The Closelooknet company score reads 36/100 composite (momentum 58, quality 29, valuation 52) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: initiation by Barclays, 2026-10-06

The Street on this name

Analyst actions and the latest print for BLCO from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Initiation Barclays — at Overweight Initiated to Overweight from Equal-Weight 2026-10-06

1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst wire → · Earnings wire →

Dividends and capital return no distribution in twelve months

Dividends and capital return

What BLCO pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Share count +0.6% in FY2025 149 m USD of stock-based compensation in the year

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Bausch + Lomb Corp (BLCO)?

Bausch + Lomb Corp trades as BLCO on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is BLCO in a Closelooknet index?

Not currently — Bausch + Lomb Corp is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

What is Bausch + Lomb Corp's Closelooknet composite score?

36 out of 100, with momentum 58, quality 29 and valuation 52 sub-scores, as of 2026-10-07. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does BLCO trade against its moving averages?

Uptrend stack intact: Trades +0.3% vs the 50-day and +3.2% vs the 200-day average, 9.2% below the 52-week high and +24.8% off the 52-week low; a golden cross printed 28 sessions ago. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Bausch + Lomb Corp compare with its peers?

Against its peer group (Medical Instruments & Supplies), Bausch + Lomb Corp (BLCO) sits 9.2% below its 52-week high, 0.3% above its 50-day average; Ansell Ltd (ANN.AU) is 0.9% below, Fisher & Paykel Healthcare Corporation Ltd (FPH.AU) is 1.2% below, Intuitive Surgical Inc (ISRG) is 32.7% below. Put any of them next to BLCO in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Bausch + Lomb Corp trade when bond yields rise?

Over the past year Bausch + Lomb Corp had a beta of 0.55 to TLT, the long-dated Treasury fund — it tends to move with bonds, higher than 57% of US names. On the 10 sessions in which long bonds fell most it moved −0.71% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does Bausch + Lomb Corp do?

Bausch + Lomb operates as an eye health company, selling across three segments: Vision Care, Pharmaceuticals and Surgical. Vision Care covers contact lenses, lens-care products, vitamins and over-the-counter eye drops. Pharmaceuticals covers treatments for glaucoma, inflammation, dry eye and retinal disease. No peer group is set for this name in our coverage; the comparison the market draws is with Alcon, another eye-care company spanning vision care, pharmaceuticals and surgical devices.

Where does Bausch + Lomb Corp sit in the AI build-out?

Bausch + Lomb holds no seat in Rubin, our AI build-out index; it sits in our broader universe under healthcare, in the medical instruments and supplies sector. Bausch + Lomb holds no seat in Rubin or our other indices, and it carries no Closelooknet score; coverage here rests on price and chart structure alone.

Does Bausch + Lomb Corp pay a dividend?

No cash distribution shows in Bausch + Lomb Corp’s price series over the last three years. The share count rose 0.6% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Bausch + Lomb Corp recently?

The most recent analyst action on Bausch + Lomb Corp on the Closelooknet wire is a initiation by Barclays on 2026-10-06 (at Overweight). 1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for BLCO, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.